Product: Drugs Recipient: Recipient Name Mr. Kenneth Nersten Choice Detox Center, Inc. dba Nofeel Choice Detox Center, Inc. dba Nofeel 552 Hamilton StreetSuite E-1Costa Mesa, CA […]

Delivery Method: UPS NEXT DAY DELIVERY Reference #: 2016-DAL-WL-26 Product: Drugs Recipient: Recipient Name Marshall A. Dunlap Recipient Title Owner Best Bentonite Best Bentonite 11650 Otis […]

Actemra (tocilizumab) Drug reaction with eosinophilia and systemic symptoms FDA is evaluating the need for regulatory action. Aliqopa (copanlisib) Cytomegalovirus infection The “Warnings and Precautions”, “Dosage […]

Acetaminophen Stevens-Johnson Syndrome FDA is evaluating the need for regulatory action. Ajovy (fremanezumab-vfrm) Vyepti (eptinezumab-jjmr) Anaphylactic reaction The “Contraindications”, “Warnings and Precautions”, “Adverse Reactions”, and “Patient […]

Actemra (tocilizumab) Hepatitis B reactivation FDA determined that no action is necessary at this time based on available information. Alcohol containing hand sanitizers Blood methanol induced […]

Aimovig (erenumab-aooe) Wrong strength FDA decided that no action is necessary at this time based on available information. Aimovig (erenumab-aooe) Product preparation error The carton labeling, […]

Bridion (sugammadex) injection Arteriospasm coronary (coronary vasospasm) The “Adverse Reactions” section of the labeling was updated in January 2021 to include coronary spasm. Bridion labeling Bydureon […]

CisplatinGeneric products containing cisplatin Aortic thrombosis FDA has determined that the last approved labeling is adequate, and that no further regulatory action is needed at this […]

For Immediate Release: March 04, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, […]